165 related articles for article (PubMed ID: 681240)
1. Studies on the biosynthesis of clavulanic acid. I. Incorporation of 13C-labelled precursors.
Elson SW; Oliver RS
J Antibiot (Tokyo); 1978 Jun; 31(6):586-92. PubMed ID: 681240
[TBL] [Abstract][Full Text] [Related]
2. Studies on the biosynthesis of clavulanic acid. III. Incorporation of DL-[3,4-13C2]glutamic acid.
Elson SW; Oliver RS; Bycroft BW; Faruk EA
J Antibiot (Tokyo); 1982 Jan; 35(1):81-6. PubMed ID: 6121786
[TBL] [Abstract][Full Text] [Related]
3. Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus.
Reading C; Cole M
Antimicrob Agents Chemother; 1977 May; 11(5):852-7. PubMed ID: 879738
[TBL] [Abstract][Full Text] [Related]
4. Studies on the biosynthesis of clavulanic acid. II. Chemical degradations of 14C-labelled clavulanic acid.
Stirling I; Elson SW
J Antibiot (Tokyo); 1979 Nov; 32(11):1125-9. PubMed ID: 528382
[TBL] [Abstract][Full Text] [Related]
5. Four further antibiotics related to olivanic acid produced by Streptomyces olivaceus: fermentation, isolation, characterisation and biosynthetic studies.
Box SJ; Hood JD; Spear SR
J Antibiot (Tokyo); 1979 Dec; 32(12):1239-47. PubMed ID: 317283
[TBL] [Abstract][Full Text] [Related]
6. Biosynthesis and molecular genetics of clavulanic acid.
Jensen SE; Paradkar AS
Antonie Van Leeuwenhoek; 1999; 75(1-2):125-33. PubMed ID: 10422585
[TBL] [Abstract][Full Text] [Related]
7. Interaction of beta-lactamase of Streptomyces cacaoi. I. Clavulanic acid and PS-5.
Ogawara H; Mantoku A
J Antibiot (Tokyo); 1981 Oct; 34(10):1341-6. PubMed ID: 6975771
[TBL] [Abstract][Full Text] [Related]
8. Olivanic acids, a family of beta-lactam antibiotics with beta-lactamase inhibitory properties produced by Streptomyces species. II. Isolation and characterisation of the olivanic acids MM 4550, MM 13902 and MM 17880 from Streptomyces olivaceus.
Hood JD; Box SJ; Verrall MS
J Antibiot (Tokyo); 1979 Apr; 32(4):295-304. PubMed ID: 468716
[TBL] [Abstract][Full Text] [Related]
9. Olivanic acids, a family of beta-lactam antibiotics with beta-lactamase inhibitory properties produced by Streptomyces species. I. Detection, properties and fermentation studies.
Butterworth D; Cole M; Hanscomb G; Rolinson GN
J Antibiot (Tokyo); 1979 Apr; 32(4):287-94. PubMed ID: 468715
[TBL] [Abstract][Full Text] [Related]
10. Natural beta-lactam antibiotics.
Aoki H; Okuhara M
Annu Rev Microbiol; 1980; 34():159-81. PubMed ID: 7002023
[No Abstract] [Full Text] [Related]
11. Glutamate as the common precursor for the aglycon of the naturally occurring C-nucleoside antibiotics.
Suhadolnik RJ; Reichenbach NL
Biochemistry; 1981 Nov; 20(24):7042-6. PubMed ID: 6119109
[TBL] [Abstract][Full Text] [Related]
12. Streptomyces clavuligerus shows a strong association between TCA cycle intermediate accumulation and clavulanic acid biosynthesis.
Ramirez-Malule H; Junne S; Nicolás Cruz-Bournazou M; Neubauer P; Ríos-Estepa R
Appl Microbiol Biotechnol; 2018 May; 102(9):4009-4023. PubMed ID: 29523936
[TBL] [Abstract][Full Text] [Related]
13. Milbemycins, a new family of macrolide antibiotics. Studies on the biosynthesis of milbemycins alpha 2, alpha 4 and D using 13C labeled precursors.
Ono M; Mishima H; Takiguchi Y; Terao M; Kobayashi H; Iwasaki S; Okuda S
J Antibiot (Tokyo); 1983 Aug; 36(8):991-1000. PubMed ID: 6630070
[TBL] [Abstract][Full Text] [Related]
14. Biosynthetic origin of the carbon skeleton and oxygen atoms of the LL-F28249 alpha, a potent antiparasitic macrolide.
Tsou HR; Ahmed ZH; Fiala RR; Bullock MW; Carter GT; Goodman JJ; Borders DB
J Antibiot (Tokyo); 1989 Mar; 42(3):398-406. PubMed ID: 2708133
[TBL] [Abstract][Full Text] [Related]
15. Studies on the biosynthesis of 16-membered macrolide antibiotics using carbon-13 nuclear magnetic resonance spectroscopy.
Omura S; Takeshima H; Nakagawa A; Miyazawa J; Piriou F; Lukacs G
Biochemistry; 1977 Jun; 16(13):2860-6. PubMed ID: 18162
[TBL] [Abstract][Full Text] [Related]
16. A statistical approach using L(25) orthogonal array method to study fermentative production of clavulanic acid by Streptomyces clavuligerus MTCC 1142.
Saudagar PS; Singhal RS
Appl Biochem Biotechnol; 2007 Mar; 136(3):345-59. PubMed ID: 17625238
[TBL] [Abstract][Full Text] [Related]
17. Enhanced biosynthesis of clavulanic acid in Streptomyces clavuligerus due to oxidative challenge by redox-cycling agents.
Kwon HJ; Kim SU
Appl Microbiol Biotechnol; 1998 Jan; 49(1):77-83. PubMed ID: 9487713
[TBL] [Abstract][Full Text] [Related]
18. Asparenomycin A, a new carbapenem antibiotic.
Tanaka K; Shoji J; Terui Y; Tsuji N; Kondo E; Mayama M; Kawamura Y; Hattori T; Matsumoto K; Yoshida T
J Antibiot (Tokyo); 1981 Jul; 34(7):909-11. PubMed ID: 6974725
[No Abstract] [Full Text] [Related]
19. Clavulanic acid, a beta-lactamase inhibitor: biosynthesis and molecular genetics.
Liras P; Rodríguez-García A
Appl Microbiol Biotechnol; 2000 Oct; 54(4):467-75. PubMed ID: 11092620
[TBL] [Abstract][Full Text] [Related]
20. Clavulanic acid biosynthesis and genetic manipulation for its overproduction.
Song JY; Jensen SE; Lee KJ
Appl Microbiol Biotechnol; 2010 Oct; 88(3):659-69. PubMed ID: 20711575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
